DAP Guidelines and Whether Change is Needed

Video

The use of dual anti platelet therapy is popular among cardio patients but questions remain of how long that therapy should continue after a cardiac event.

The use of dual anti platelet therapy is popular among cardio patients but questions remain of how long that therapy should continue after a cardiac event.

Robert Yeh, MD, MPH, from Massachusetts General Hospital discussed the results of a study on the topic at the American College of Cardiology Annual Scientific Sessions and Expo in San Diego.

Related Videos
Optimizing Diabetes Therapies with New Classifications
Anthony Lembo, MD | Credit: Cleveland Clinic
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Noa Krugliak Cleveland, MD | Credit: University of Chicago
© 2024 MJH Life Sciences

All rights reserved.